Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rao V et al. - There are no FDA approved therapies for sarcoidosis. Corticosteroids remain the standard of care. Corticosteroid sparing agents may be used in patients with progressive disease. The use of tumor necrosis factor inhibitors may be effective in refractory cases.

Related Articles

The role of EBUS-TBNA for the diagnosis of sarcoidosis – comparisons with other bronchoscopic diagnostic modalities
Respiratory Medicine, 11/18/09    Relevance Score: 89%

Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2
American Journal of Respiratory and Critical Care Medicine, 11/13/09    Relevance Score: 89%

The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis
European Respiratory Journal, 11/11/09    Relevance Score: 89%

Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature
Respiration, 10/06/09    Relevance Score: 88%

Sarcoidosis of the submandibular gland: A systematic review
American Journal of Otolaryngology, 10/15/09    Relevance Score: 87%

Today in Sarcoidosis...keeping you current

Functional analysis of dendritic cell–T cell interaction in sarcoidosis
Clinical and Experimental Immunology, 12/03/09

Acute-onset sarcoidosis with polyarthralgia and hilar lymphadenopathy
Modern Rheumatology, 12/01/09

Prevalence of sarcoidosis in Switzerland is associated with environmental factors
European Respiratory Journal , 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address